| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |